Do you want to know more about Parkinson's? PDF's materials provide information about symptoms, medications, resources & more.
Parkinson's Disease Foundation Hails New Korean Stem Cell Study Involving Embryonic Stem Cells
New York, NY - Feb 12 2004
Todayís news that scientists in South Korea have succeeded in deriving human embryonic stem cells from a cloned embryo is an important step forward in the exploration of the potential of this science for easing and solving human diseases, said officials of the Parkinsonís Disease Foundation (PDF).
Dr. Stanley Fahn, PDFís scientific director and Columbia University professor who recently completed a two-year term as President of the American Academy of Neurology, described the statement as ďencouraging news from qualified investigators on their work in an area that could hold much promise for the solution of a variety of human diseases, including Parkinsonís.Ē He cautioned, however, that the therapeutic promise of somatic cell nuclear transfer, in which the nucleus of a cell is transferred into a nucleus-free egg from the same donor, is ďneither certain nor immediate. But it deserves serious exploration, for the sake of millions of sufferers around the world who could potentially benefit from it in the long run.Ē
Individuals who are interested in exploring these issues further are encouraged to check the website of the Coalition for the Advancement of Medical Research (CAMR) at www.camradvocacy.org, a nationwide coalition of disease advocacy groups that support this kind of research and favor public policies permitting scientists to pursue such research. PDF, along with the Washington-based Parkinsonís Action Network, are active members of CAMR.
To review the full-text of the article"Stem Cells Taken In Human Cloning Seoul study: Focus on disease treatment -- not making babies" By GINA KOLATA,THE NEW YORK TIMES Thursday, February 12, 2004, please see: www.seattlepi.nwsource.com/national/160355_clone12.html
Source Date: Jan 12 2004
Source Publication: The New York Times / The Seattle Post Intelligencer, WA
View source URL